Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1;57(4):281-282.
doi: 10.4103/ijp.ijp_952_24. Epub 2025 Jul 21.

Zonisamide-induced vasculitis: A rare entity

Abhijit Saha  1 , Subhra Dhar  2 , Swarnali Maiti  3 , Safia Bashir  1
Affiliations

Zonisamide-induced vasculitis: A rare entity

Abhijit Saha et al. Indian J Pharmacol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
(a and b) Dusky erythematous maculopapular lesions over the whole body; (c) H and E, ×100 (d) H and E, ×400; Perivascular and intravascular neutrophilic infiltrates along with fibrinoid changes in the vessel wall with some karyorrhectic debris and extravasated red blood cells
See this image and copyright information in PMC

References

    1. Palit A, Inamadar AC. Childhood cutaneous vasculitis: A comprehensive appraisal. Indian J Dermatol. 2009;54:110–7. - PMC - PubMed
    1. Merkel PA. Drug-induced vasculitis. Rheum Dis Clin North Am. 2001;27:849–62. - PubMed
    1. Panda PK, Sharawat IK, Panda P, Dawman L. Efficacy, tolerability, and safety of zonisamide in children with epileptic spasms: A systematic review and meta-analysis. Seizure. 2021;91:374–83. - PubMed
    1. Vivar KL, Mancl K, Seminario-Vidal L. Stevens-Johnson syndrome/toxic epidermal necrolysis associated with zonisamide. Clin Case Rep. 2018;6:258–61. - PMC - PubMed

LinkOut - more resources